KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Return on Sales: 2016-2024

Historic Return on Sales for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Dec 2024 value amounting to -0.03%.

  • Amneal Pharmaceuticals' Return on Sales rose 7.00% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 7.00%. This contributed to the annual value of -0.03% for FY2024, which is 1.00% down from last year.
  • Per Amneal Pharmaceuticals' latest filing, its Return on Sales stood at -0.03% for FY2024, which was down 29.84% from -0.02% recorded in FY2023.
  • In the past 5 years, Amneal Pharmaceuticals' Return on Sales registered a high of 0.03% during FY2020, and its lowest value of -0.12% during FY2022.
  • Moreover, its 3-year median value for Return on Sales was -0.03% (2024), whereas its average is -0.05%.
  • Its Return on Sales has fluctuated over the past 5 years, first spiked by 41bps in 2020, then declined by 12bps in 2022.
  • Amneal Pharmaceuticals' Return on Sales (Yearly) stood at 0.03% in 2020, then dropped by 2bps to 0.01% in 2021, then fell by 12bps to -0.12% in 2022, then grew by 9bps to -0.02% in 2023, then declined by 1bps to -0.03% in 2024.